Search Results - "Kononova, N. V"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
  2. 2

    Development and optimization of several stages of the technological process of filgrastim substance production by Kononova, N. V, Bobruskin, A. I, Kostromina, T. I, Melikhova, T. D, Vainson, A. A, Sveshnikova, E. V, Zinchenko, A. A, Demin, A. V, Martyanov, V. A, Shuster, A. M, Bairamashvili, D. I

    Published in Applied biochemistry and microbiology (01-12-2010)
    “…Technology of industrial production of an active pharmaceutical substance (APS) of the recombinant human granulocyte colony-stimulating factor (rhG-CSF)…”
    Get full text
    Journal Article
  3. 3

    The use of ridge regression for estimating the severity of acute pancreatitis by Cherdantsev, D. V., Stroev, A. V., Mangalova, E. S., Kononova, N. V., Chubarova, O. V.

    Published in Bi͡u︡lletenʹ Sibirskoĭ medit͡s︡iny (27-10-2019)
    “…Purpose. Increasing of treatment efficiency for patients with acute pancreatitis by improving objective means of determining the severity of acute…”
    Get full text
    Journal Article
  4. 4

    Recombinant granulocyte colony-stimulating factor (filgrastim): Optimization of conjugation conditions with polyethylene glycol by Puchkov, I. A., Kononova, N. V., Bobruskin, A. I., Bairamashvili, D. I., Mart’yanov, V. A., Shuster, A. M.

    Published in Russian journal of bioorganic chemistry (01-09-2012)
    “…With the purpose of creating an active prolonged-release pharmaceutical substance, modification of the recombinant human granulocyte colony-stimulating factor…”
    Get full text
    Journal Article
  5. 5

    Recombinant granulocyte-colony stimulating factor (filgrastim): optimization of conditions of isolation and purification from inclusion body by Kononova, N V, Iakovlev, A V, Zhuravko, A M, Pankeev, N N, Minaev, S V, Bobruskin, A I, Mart'ianov, V A

    Published in Bioorganicheskaia khimiia (01-09-2014)
    “…We developed a unified process platform for two recombinant human GCSF medicines--one with the non-prolonged and the other with prolonged action. This unified…”
    Get more information
    Journal Article
  6. 6

    Recombinant granulocyte-colony stimulating factor (filgrastim): optimization of conjugation with polyethylene glycol by Puchkov, I A, Kononova, N V, Bobruskin, A I, Bairamashvili, D I, Mart'ianov, V A, Shuster, A M

    Published in Bioorganicheskaia khimiia (01-09-2012)
    “…In order to create an active pharmaceutical substance of the drug with prolonged action the modification of recombinant human granulocyte colony-stimulating…”
    Get more information
    Journal Article
  7. 7

    Solubilization Specificities Interferon beta-1b from Inclusion Bodies by Zhuravko, A S, Kononova, N V, Bobruskin, A I

    Published in Bioorganicheskaia khimiia (01-07-2015)
    “…A new solubilization method of recombinant interferon beta-1b (IFNβ-1b) from the inclusion bodies was developed. This method allows to extract the target…”
    Get more information
    Journal Article
  8. 8

    Features of the solubilization of interferon beta-1B from inclusion bodies by Zhuravko, A. S., Kononova, N. V., Bobruskin, A. I.

    Published in Russian journal of bioorganic chemistry (01-07-2015)
    “…A novel method for the solubilization of recombinant interferon beta-1b (IFNβ-1b) from inclusion bodies has been developed, which makes it possible to…”
    Get full text
    Journal Article
  9. 9

    Recombinant granulocyte colony stimulating factor (filgrastim) of prolonged action: Optimization of conditions for extraction and purification from inclusion bodies by Kononova, N. V., Yakovlev, A. V., Zhuravko, A. M., Pankeev, N. N., Minaev, S. V., Bobruskin, A. I., Mart’yanov, V. A.

    Published in Russian journal of bioorganic chemistry (01-09-2014)
    “…A unified technology platform for the production of two medical products with nonprolonged and prolonged action on the basis of the recombinant human…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Identification and structural analysis of a glycophospholipid component from the venom of ant Paraponera clavata by Pluzhnikov, K A, Bocharov, D N, Kononova, N V, Sukhanov, S V, Balashova, T A, Arsen'ev, A S, Grishin, E V

    Published in Bioorganicheskaia khimiia (01-09-2006)
    “…The venom of South American ant Paraponera clavata and its low-molecular-mass fraction were shown to possess insectotoxic and pore-forming activities. A number…”
    Get more information
    Journal Article
  12. 12